Amount, a company that provides technology to banks and financial institutions, has raised $99 million in a Series D funding round at a valuation of just over $1 billion.
Excision BioTherapeutics (“Excision”), a leading developer of potentially curative CRISPR anti-viral therapies to improve patient lives, today announced the completion of a $60 million financing.
The virus might be deadly but a lack of compassion is surely fatal to humanity
Researchers say they have removed HIV from the DNA of mice, an achievement the scientists say could be an early step toward an elusive cure for humans.
The Myanmar Opportunities Fund II secures US$30m from ACE & Co, The KALE Foundation, and family offices. Targeting US$70m, it is in talks with IFC, NorFund, and CDC to drive Myanmar’s development.